Edsjö Anders, Friedman Mikaela, Rosenquist Richard
PhD, överläkare, klinisk genetik och patologi,, Skånes universitetssjukhus; Lunds universitet.
PhD, forskningskoordinator, Karolinska institutet.
Lakartidningen. 2021 May 11;118:21023.
The Genomic Medicine Sweden (GMS) initiative aims to strengthen precision medicine across the country. This will be accomplished through the implementation of large-scale sequencing techniques in Swedish healthcare. With a patient-centered view, initial efforts will focus on rare diseases, cancer, pharmacogenomics, and infectious diseases, and subsequently extend to complex diseases. GMS is being implemented as a broad collaborative project involving healthcare, universities with medical faculty, SciLifeLab, industry and patient organizations. To deliver top tier diagnostics, regional genomic medicine centers (GMC) are currently under establishment together with a national informatics infrastructure for data sharing. GMS will also offer a unique resource for research that could pave the way for the development of novel drugs, and enhance collaboration with industry. In summary, GMS provides Sweden with an opportunity to take an international forefront position in the field of precision medicine.
瑞典基因组医学（GMS）倡议旨在加强全国范围内的精准医学。这将通过在瑞典医疗保健领域实施大规模测序技术来实现。从以患者为中心的角度出发，初期工作将聚焦于罕见病、癌症、药物基因组学和传染病，随后扩展至复杂疾病。GMS作为一个广泛的合作项目正在实施，参与方包括医疗保健机构、设有医学院的大学、SciLifeLab、行业和患者组织。为提供顶级诊断，目前正在建立区域基因组医学中心（GMC）以及用于数据共享的国家信息基础设施。GMS还将为研究提供独特资源，这可能为新型药物的开发铺平道路，并加强与行业的合作。总之，GMS为瑞典提供了一个在精准医学领域占据国际前沿地位的机会。
